Skip to main content
Mass General BrighamPatent grant

Massachusetts Eye and Ear Infirmary was granted a patent for anti-APOE therapies.

Source: Autobound Signal API · 75 signals tracked for Mass General Brigham · updated

Get Mass General Brigham's live signals in Claude or ChatGPT, or by API

AskWhat changed at Mass General Brigham this week? Use Autobound signals for massgeneralbrigham.org.

What happened

In October 2026 the institution patented antibody and genetic approaches for preventing or treating cognitive decline, dementia, and neurodegeneration in clinical care.

Source

patents.google.comOct 27, 2026

US patent US12774323

Anti-apolipoprotein e (APOE) antibodies and polynucleotides thereof

Abstract

Methods and compositions for preventing or treating cognitive decline associated with dementia and/or mild cognitive impairment and/or neurodegeneration using antibodies, peptides, fusion proteins, or genome editing systems that modulate HSPG/heparin binding affinities of ApoE.

patents.google.com/patent/US12774323Read the full source

Extracted by Autobound

From the Signal API record
Signal
Patent grant

What this signalsA new patent often shows where a company is putting its R&D budget.

Grant date
Oct 27, 2026
Inventors
4
Patent number
US12774323
Assignee
Massachusetts Eye and Ear Infirmary

The full record

From the Signal API record

People

  • Yakeel T. QuirozInventor
  • Joseph F. Arboleda-VelasquezInventor
  • Eric ReimanInventor
  • Francisco LoperaInventor

Details

Primary CPC class
C07K 16/18
USPTO assignee
Massachusetts Eye and Ear Infirmary
What the invention does
Treatments that alter how APOE binds to cell-surface molecules, aiming to reduce processes linked to memory loss and brain degeneration.

Topics and mentions

Tags

  • Intellectual Property
  • Research & Development
  • Healthcare Technology
  • Medical Research
  • Pharmaceuticals

Technologies named

  • APOE antibodies
  • therapeutic proteins
  • genome editing

Extraction

Detected
Oct 30, 2026
signal_type
patents-company
signal_subtype
patentGrant

Use this data

Get every patent signal for Mass General Brigham and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Mass General Brigham this week?”

  2. Send it to your own tools

    The Signal API returns patent signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full patents-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/084e3e05-bc32-594d-90e1-6680e6ca7942 returns this record as JSON. POST /v1/companies/enrich returns every signal for massgeneralbrigham.org.

{
  "signal_id": "084e3e05-bc32-594d-90e1-6680e6ca7942",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-10-30T00:09:17+00:00",
  "company": {
    "name": "Mass General Brigham",
    "domain": "massgeneralbrigham.org"
  },
  "data": {
    "cpc": [
      {
        "code": "C07K 16/18"
      },
      {
        "code": "A61K 39/395"
      },
      {
        "code": "A61P 25/28"
      },
      {
        "code": "C07K 14/775"
      },
      {
        "code": "C12N 15/00"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Healthcare Technology",
      "Medical Research",
      "Pharmaceuticals"
    ],
    "detail": "In October 2026 the institution patented antibody and genetic approaches for preventing or treating cognitive decline, dementia, and neurodegeneration in clinical care.",
    "summary": "Massachusetts Eye and Ear Infirmary was granted a patent for anti-APOE therapies.",
    "event_at": "2026-10-27",
    "inventors": [
      {
        "name": "Yakeel T. Quiroz",
        "status": "resolved",
        "is_primary": true,
        "linkedin_url": "https://www.linkedin.com/in/yakeel-t-quiroz-phd-23722615"
      },
      {
        "name": "Joseph F. Arboleda-Velasquez",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/joseph-arboleda-velasquez-1179a229"
      },
      {
        "name": "Eric Reiman",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Francisco Lopera",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/francisco-lopera-290a7846"
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-10-27",
    "source_url": "https://patents.google.com/patent/US12774323",
    "cpc_primary": {
      "code": "C07K 16/18"
    },
    "patent_title": "Anti-apolipoprotein e (APOE) antibodies and polynucleotides thereof",
    "patent_number": "US12774323",
    "uspto_assignee": "Massachusetts Eye and Ear Infirmary",
    "patent_abstract": "Methods and compositions for preventing or treating cognitive decline associated with dementia and/or mild cognitive impairment and/or neurodegeneration using antibodies, peptides, fusion proteins, or genome editing systems that modulate HSPG/heparin binding affinities of ApoE.",
    "precision_class": "structural",
    "invention_explanation": "Treatments that alter how APOE binds to cell-surface molecules, aiming to reduce processes linked to memory loss and brain degeneration.",
    "technologies_mentioned": [
      "APOE antibodies",
      "therapeutic proteins",
      "genome editing"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.